Meropenem Steriscience

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats severe bacterial infections such as intra‑abdominal, urinary tract, respiratory and central nervous system infections in hospitalized adult patients and is indicated for use in critical‑care settings.

GNH USA supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, adhering to European Union quality standards and GMP manufacturing practices.

Meropenem is a broad‑spectrum carbapenem used to treat serious bacterial infections affecting various organ systems.

- Complicated intra‑abdominal infections: effective against the polymicrobial pathogens causing these infections. - Complicated urinary tract infections: eradicates Gram‑negative and Gram‑positive organisms in the urinary tract. - Nosocomial pneumonia: provides coverage for resistant respiratory pathogens acquired in hospital settings. - Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis. - Severe sepsis and septic shock: used as part of empiric therapy for life‑threatening systemic infections.

Meropenem may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Rash

Serious or Rare Side Effects: - Seizures, especially in patients with renal impairment or CNS disorders - Clostridioides difficile‑associated colitis - Anaphylaxis or severe hypersensitivity reactions - Acute renal dysfunction or worsening of pre‑existing kidney disease

Meropenem should be used with caution in specific clinical situations.

- Renal function: adjust dose in patients with impaired renal clearance. - Seizure risk: monitor patients with a history of epilepsy or other central nervous system disorders. - Hypersensitivity: discontinue immediately if signs of allergic reaction appear. - Antibiotic stewardship: reserve for confirmed bacterial infections to limit resistance development. - Pregnancy and lactation: safety not established; benefits must outweigh potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem can interact with other medicines, requiring attention to dosage and monitoring.

Major Interactions (Avoid): - Valproic acid: may lower serum valproate concentrations, reducing seizure control. - Probenecid: can increase meropenem plasma levels, raising toxicity risk. - Cytotoxic chemotherapy agents: heightened risk of nephrotoxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor renal function and electrolytes. - Aminoglycosides: increased potential for kidney injury; assess renal parameters. - Anticoagulants (e.g., warfarin): observe coagulation status for possible alterations.